Leptin causes body weight loss in the absence of in vivo activities typical of cytokines of the IL-6 family

被引:10
作者
Agnello, D
Meazza, C
Rowan, CG
Villa, P
Ghezzi, P
Senaldi, G
机构
[1] Amgen Inc, Amgen Ctr, Thousand Oaks, CA 91320 USA
[2] Mario Negri Inst Pharmacol Res, I-20157 Milan, Italy
[3] Stanford Univ, Dept Genet, Stanford, CA 94305 USA
关键词
corticosterone; interleukin-1; leukemia inhibitory factor; peripheral blood cells; tumor necrosis factor;
D O I
10.1152/ajpregu.1998.275.3.R913
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
To investigate if leptin shares in vivo activities with interleukin (IL)-6 family cytokines, it was tested in normal mice for the ability, after a single injection, to induce the acute-phase protein serum amyloid A, to potentiate the induction by IL-1 of serum corticosterone and IL-6, and to inhibit the induction by lipopolysaccharide of serum tumor necrosis factor and, after seven daily injections, to cause body weight loss and to change peripheral blood cell counts. At a 0.5 mg/kg dose, leptin caused body weight loss but did not show any of the other activities above. At a dose of 5 mg/kg, which also caused body weight loss, leptin potentiated the induction by IL-1 of serum corticosterone and IL-6 but did not show any other activity. In addition to causing body weight loss, leptin shows only some of the in vivo activities typical of IL-6 family cytokines and only if used at a dose that exceeds the one sufficient to affect body weight. In vivo, leptin seems to chiefly control body weight and not inflammatory or hematopoietic processes.
引用
收藏
页码:R913 / R919
页数:7
相关论文
共 45 条
  • [1] ADERKA D, 1989, J IMMUNOL, V143, P3517
  • [2] AGGARWAL BB, 1985, J BIOL CHEM, V260, P2345
  • [3] DIFFERENTIATION FACTOR LEUKEMIA INHIBITORY FACTOR PROTECTION AGAINST LETHAL ENDOTOXEMIA IN MICE - SYNERGISTIC EFFECT WITH INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR
    ALEXANDER, HR
    WONG, GGH
    DOHERTY, GM
    VENZON, DJ
    FRAKER, DL
    NORTON, JA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (04) : 1139 - 1142
  • [4] Interleukins 6 and 11 protect mice from mortality in a staphylococcal enterotoxin-induced toxic shock model
    Barton, BE
    Shortall, J
    Jackson, JV
    [J]. INFECTION AND IMMUNITY, 1996, 64 (03) : 714 - 718
  • [5] The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors
    Baumann, H
    Morella, KK
    White, DW
    Dembski, M
    Bailon, PS
    Kim, HK
    Lai, CF
    Tartaglia, LA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (16) : 8374 - 8378
  • [6] Six different cytokines that share GP130 as a receptor subunit, induce serum amyloid A and potentiate the induction of interleukin-6 and the activation of the hypothalamus-pituitary-adrenal axis by interleukin-1
    Benigni, F
    Fantuzzi, G
    Sacco, S
    Sironi, M
    Pozzi, P
    Dinarello, CA
    Sipe, JD
    Poli, V
    Cappelletti, M
    Paonessa, G
    Pennica, D
    Panayotatos, N
    Ghezzi, P
    [J]. BLOOD, 1996, 87 (05) : 1851 - 1854
  • [7] Benigni F, 1996, AM J PATHOL, V149, P1847
  • [8] CILIARY NEUROTROPHIC FACTOR INHIBITS BRAIN AND PERIPHERAL TUMOR-NECROSIS-FACTOR PRODUCTION AND, WHEN COADMINISTERED WITH ITS SOLUBLE RECEPTOR, PROTECTS MICE FROM LIPOPOLYSACCHARIDE TOXICITY
    BENIGNI, F
    VILLA, P
    DEMITRI, MT
    SACCO, S
    SIPE, JD
    LAGUNOWICH, L
    PANAYOTATOS, N
    GHEZZI, P
    [J]. MOLECULAR MEDICINE, 1995, 1 (05) : 568 - 575
  • [9] Evidence that the diabetes gene encodes the leptin receptor: Identification of a mutation in the leptin receptor gene in db/db mice
    Chen, H
    Charlat, O
    Tartaglia, LA
    Woolf, EA
    Weng, X
    Ellis, SJ
    Lakey, ND
    Culpepper, J
    Moore, KJ
    Breitbart, RE
    Duyk, GM
    Tepper, RI
    Morgenstern, JP
    [J]. CELL, 1996, 84 (03) : 491 - 495
  • [10] Novel B219/OB receptor isoforms: Possible role of leptin in hematopoiesis and reproduction
    Cioffi, JA
    Shafer, AW
    Zupancic, TJ
    SmithGbur, J
    Mikhail, A
    Platika, D
    Snodgrass, HR
    [J]. NATURE MEDICINE, 1996, 2 (05) : 585 - 589